NEW YORK, Jan. 25, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
The Drug Discovery Outsourcing Market
http://www.reportlinker.com/p0363588/The-Drug-Discovery-Outsourcing-Market.html
Introduction
This report investigates current trends and opportunities
affecting decisions on whether or not to outsource drug discovery.
Outsourcing to low cost offshore destinations such as China and
India are examined in detail. The report also covers a variety of
strategic collaborations, academic partnerships and outsourcing
opportunities along with case studies.
Features and benefits
* Develop an informed perspective of the drug discovery process
including the role of outsourcing.* Understand the pros and cons of
drug discovery outsourcing.* Gain an understanding of the current
trends and opportunities in global drug discovery outsourcing
market.* Compare the leading ten drug discovery service provider’s
strategies and capabilities.* Assess China and India as drug
discovery outsourcing destinations.
Highlights
As pharma companies relax their conservatism towards drug
discovery outsourcing the market, which was valued at $7.4bn in
2009 is expected to increase to $18.5bn by 2015. Among discovery
outsourcing services, chemistry services represented the leading
category of outsourced drug discovery services generating around
$2.9bn in sales, accounting for a market share of 39%. Biological
services accounted for $2bn with a market share of 28%, which is
expected to increase in the future. The networked pharma model
under which companies reduce their footprint of owned facilities in
favour of a ne
‘/>”/>
SOURCE